Download PDF
Thorac Cardiovasc Surg 2010; 58: S189-S193
DOI: 10.1055/s-0029-1240684
Originals

© Georg Thieme Verlag KG Stuttgart · New York

German Disease Management Guidelines: Surgical Therapies for Chronic Heart Failure

J. R. Sindermann1 , S. Klotz1 , K. Rahbar2 , A. Hoffmeier1 , G. Drees1
  • 1Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Muenster, Muenster, Germany
  • 2Department of Nuclear Medicine, Hospital of the University of Muenster, Muenster, Germany
Further Information

Publication History

Publication Date:
25 January 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

The German Disease Management Guideline “Chronic Heart Failure” intends to guide physicians working in the field of diagnosis and treatment of heart failure. The guideline provides a tool on the background of evidence based medicine. The following short review wants to give insights into the role of some surgical treatment options to improve heart failure, such as revascularization, ventricular reconstruction and aneurysmectomy, mitral valve reconstruction, ventricular assist devices and heart transplantation.

Key words

chronic heart failure - evidence based medicine - surgery

References

  • 1 Scottish Intercollegiate Guidelines Network (SIGN) .Management of chronic heart failure. Edinburgh; SIGN 2007 http://www.sign.ac.uk/guidelines/published/numlist.html
    Google Scholar
  • 2 Tsuyuki R T, Shrive F M, Galbraith P D, Knudtson M L, Graham M M. Revascularization in patients with heart failure.  CMAJ. 2006;  175 (4) 361-365
    PubMedGoogle Scholar
  • 3 Jones R H, Velazquez E J, Michler R E, Sopko G, Oh J K, O'Connor C M, Hill J A, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau J L, Lee K L. STICH hypothesis 2 investigators. Coronary bypass surgery with or without surgical ventricular reconstruction.  N Engl J Med. 2009;  360 (17) 1705-1717
    CrossrefPubMedGoogle Scholar
  • 4 Buszman P, Szkróbka I, Gruszka A, Parma R, Tendera Z, Leśko B, Wilczyński M, Bochenek T, Wojakowski W, Bochenek A, Tendera M. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy.  Am J Cardiol. 2007;  99 (1) 36-41
    CrossrefPubMedGoogle Scholar
  • 5 Simpson S H, Majumdar S R, Tsuyuki R T, Eurich D T, Johnson J A. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.  CMAJ. 2006;  174 (2) 169-174
    CrossrefPubMedGoogle Scholar
  • 6 Baker D W, Jones R, Hodges J, Massie B M, Konstam M A, Rose E A. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.  JAMA. 1994;  272 (19) 1528-1534
    CrossrefPubMedGoogle Scholar
  • 7 Muhlbaier L H, Pryor D B, Rankin J S, Smith L R, Mark D B, Jones R H, Glower D D, Harrell Jr F E, Lee K L, Califf R M. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up.  Circulation. 1992;  86 (Suppl. 5) II198-II204
    PubMedGoogle Scholar
  • 8 Stahle E, Bergstrom R, Edlund B, Frostfeldt G, Lagerquist B, Sjogren I, Hansson H E. Influence of left ventricular function on survival after coronary artery bypass grafting.  Ann Thorac Surg. 1997;  64 (2) 437-444
    CrossrefPubMedGoogle Scholar
  • 9 Alderman E L, Fisher L D, Litwin P, Kaiser G C, Myers W O, Maynard C, Levine F, Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (CASS).  Circulation. 1983;  68 (4) 785-795
    PubMedGoogle Scholar
  • 10 Patel M R, Dehmer G J, Hirshfeld J W, Smith P K, Spertus J A. American College of Cardiology Foundation Appropriateness Criteria Task Force . ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.  J Am Coll Cardiol. 2009;  53 (6) 530-553
    CrossrefPubMedGoogle Scholar
  • 11 Di Carli M F, Davidson M, Little R, Khanna S, Mody F V, Brunken R C, Czernin J, Rokhsar S, Stevenson L W, Laks H. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.  Am J Cardiol. 1994;  73 (8) 527-533
    CrossrefPubMedGoogle Scholar
  • 12 Hausmann H, Topp H, Siniawski H, Holz S, Hetzer R. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation?.  Ann Thorac Surg. 1997;  64 (5) 1296-1301
    CrossrefPubMedGoogle Scholar
  • 13 Westaby S. Non-transplant surgery for heart failure.  Heart. 2000;  83 (5) 603-610
    CrossrefPubMedGoogle Scholar
  • 14 Dor V, Sabatier M, Di Donato M, Montiglio F, Toso A, Maioli M. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars.  J Thorac Cardiovasc Surg. 1998;  116 (1) 50-59
    CrossrefPubMedGoogle Scholar
  • 15 Menicanti L, Di Donato M. Left ventricular restoration: how important is the surgical treatment of ischemic heart failure trial?.  Heart Fail Clin. 2007;  3 (2) 237-243
    CrossrefPubMedGoogle Scholar
  • 16 Westaby S. Heart failure surgery: a speciality in itself.  Scand J Surg. 2007;  96 (2) 140-153
    PubMedGoogle Scholar
  • 17 Large S. Surgery for heart failure.  Heart. 2007;  93 (3) 392-402
    CrossrefPubMedGoogle Scholar
  • 18 Bonow R O, Carabello B A, Kanu C, de Leon Jr A C, Faxon D P, Freed M D, Gaasch W H, Lytle B W, Nishimura R A, O'Gara P T, O'Rourke R A, Otto C M, Shah P M, Shanewise J S, Smith Jr S C, Jacobs A K, Adams C D, Anderson J L, Antman E M, Faxon D P, Fuster V, Halperin J L, Hiratzka L F, Hunt S A, Lytle B W, Nishimura R, Page R L, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.  Circulation. 2006;  114 (5) e84-e231
    CrossrefPubMedGoogle Scholar
  • 19 Otto C M. Timing of surgery in mitral regurgitation.  Heart. 2003;  89 (1) 100-105
    CrossrefPubMedGoogle Scholar
  • 20 Otto C M. Clinical practice. Evaluation and management of chronic mitral regurgitation.  N Engl J Med. 2001;  345 (10) 740-746
    CrossrefPubMedGoogle Scholar
  • 21 Bolling S, Pagani F D, Deeb G M, Bach D S. Intermediate-term outcome of mitral reconstruction in cardiomyopathy.  J Thorac Cardiovasc Surg. 1998;  115 381-386
    CrossrefPubMedGoogle Scholar
  • 22 Romano M A, Bolling S F. Mitral valve repair as an alternative treatment for heart failure patients.  Heart Fail Monit. 2003;  4 (1) 7-12
    PubMedGoogle Scholar
  • 23 Gummert J F, Rahmel A, Bucerius J, Onnasch J, Doll N, Walther T, Falk V, Mohr F W. Mitral valve repair in patients with end stage cardiomyopathy: who benefits?.  Eur J Cardiothorac Surg. 2003;  23 (6) 1017-1022
    CrossrefPubMedGoogle Scholar
  • 24 Rose E A, Gelijns A C, Moskowitz A J, Heitjan D F, Stevenson L W, Dembitsky W, Long J W, Ascheim D D, Tierney A R, Levitan R G, Watson J T, Meier P, Ronan N S, Shapiro P A, Lazar R M, Miller L W, Gupta L, Frazier O H, Desvigne-Nickens P, Oz M C, Poirier V L. Long-term mechanical left ventricular assistance for end-stage heart failure.  N Engl J Med. 2001;  345 (20) 1435-1443
    CrossrefPubMedGoogle Scholar
  • 25 Dembitsky W P, Tector A J, Park S, Moskowitz A J, Gelijns A C, Ronan N S, Piccione Jr W, Holman W L, Furukawa S, Weinberg A D, Heatley G, Poirier V L, Damme L, Long J W. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.  Ann Thorac Surg. 2004;  78 (6) 2123-2129
    CrossrefPubMedGoogle Scholar
  • 26 Holman W L, Park S J, Long J W, Weinberg A, Gupta L, Tierney A R, Adamson R M, Watson J D, Raines E P, Couper G S, Pagani F D, Burton N A, Miller L W, Naka Y. Infection in permanent circulatory support: experience from the REMATCH trial.  J Heart Lung Transplant. 2004;  23 (12) 1359-1365
    CrossrefPubMedGoogle Scholar
  • 27 Lazar R M, Shapiro P A, Jaski B E, Parides M K, Bourge R C, Watson J T, Damme L, Dembitsky W, Hosenpud J D, Gupta L, Tierney A, Kraus T, Naka Y. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience.  Circulation. 2004;  109 (20) 2423-2427
    CrossrefPubMedGoogle Scholar
  • 28 Scottish Intercollegiate Guidelines Network (SIGN) .Management of chronic heart failure. A national clinical guideline. Edinburgh; SIGN 2007
    Google Scholar
  • 29 Angermayr L, Velasco Garrido M, Busse R. Künstliche Ventrikel bei fortgeschrittener Herzinsuffizienz. Köln; DAHTA@DIMDI 2007 http://gripsdb.dimdi.de/de/hta/hta_berichte/hta189_bericht_de.pdf [cited: 2008 Jan 29].
    Google Scholar
  • 30 Birks E J, Tansley P D, Hardy J, George R S, Bowles C T, Burke M, Banner N R, Khaghani A, Yacoub M H. Left ventricular assist device and drug therapy for the reversal of heart failure.  N Engl J Med. 2006;  355 (18) 1873-1884
    CrossrefPubMedGoogle Scholar
  • 31 International Society for Heart and Lung Transplantation (ISHLT) .ISHLT transplant registry quarterly reports for heart in Europe. Survival rates for transplants performed between January 1, 2003 and December 31, 2006. Based on UNOS/ISHLT data as of January 4, 2008. 2008 [cited: 2008 Jan 31]. http://www.ishlt.org/registries/quarterlyDataReportResults.asp?organ=HR&%20rptType=tx_p_surv&%20continent=3
    Google Scholar
  • 32 Ständige Impfkommission am Robert Koch Institut (STIKO) .Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiologisches Bulletin/Nr. 30. 2005 [cited: 2008 Jan 29]. http://hatzmann-radermacher.de/download/RKI-Bulletin-neu.pdf
    Google Scholar
  • 33 Ballout A, Goffin E, Yombi J C, Vandercam B. Vaccinations for adult solid organ transplant recipient: current recommendations.  Transplant Proc. 2005;  37 (6) 2826-2827
    CrossrefPubMedGoogle Scholar
  • 34 Taylor D O, Edwards L B, Boucek M M, Trulock E P, Deng M C, Keck B M, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report – 2005.  J Heart Lung Transplant. 2005;  24 (8) 945-955
    CrossrefPubMedGoogle Scholar
  • 35 Taylor D O, Edwards L B, Boucek M M, Trulock E P, Aurora P, Christie J, Dobbels F, Rahmel A O, Keck B M, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report – 2007.  J Heart Lung Transplant. 2007;  26 (8) 769-781
    CrossrefPubMedGoogle Scholar

Jürgen R. Sindermann, MD

Department of Thoracic and Cardiovascular Surgery
Hospital of the University of Muenster

Albert-Schweitzer-Straße 33

48149 Muenster

Germany

Phone: + 49 25 18 34 74 26

Fax: + 49 25 18 34 83 16

Email: sinderm@uni-muenster.de